Head and Shoulders Top Fails, Completes in this Commodities ETF 03.30.26

The pharmaceutical industry is seeing a wave of mergers and acquisitions (M&A) aimed at boosting growth amid rising challenges. With an industry-wide shift toward consolidation, companies are navigating expiring patents, heightened R&D costs, and pricing pressures. M&A allows companies to scale, optimize pipelines, and diversify revenue sources, and this environment has piqued interest among investors…

By Lawrence G. McMillan A week ago, things looked rather bearish, with $SPX having broken down from a 5560-5650 trading range, and plummeting quickly to 5400. An oversold rally ensued, but by Wednesday of this week, $SPX was plunging again and reached that 5400 level for a second time. For whatever reason, buyers emerged en…